Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00721981
What this trial is testing

An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
AstraZeneca 120
Testing effectiveness (Phase 2)UnknownNCT05935579
What this trial is testing

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsImmunotherapy
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06282445
What this trial is testing

Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 36
Not applicableEnded earlyNCT02597075
What this trial is testing

Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy

Who this might be right for
Metastatic Colorectal Cancer
Swiss Cancer Institute 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06247956
What this trial is testing

Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer

Who this might be right for
Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 153
Testing effectiveness (Phase 2)UnknownNCT05174156
What this trial is testing

Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT01718353
What this trial is testing

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer Metastatic
Sanofi 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT06581380
What this trial is testing

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
JenKem Technology Co., Ltd. 394
Not applicableNot Yet RecruitingNCT06848426
What this trial is testing

Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

Who this might be right for
Non-Small Cell Lung CancerNon-small Cell Lung Cancer RecurrentNon-small Cell Lung Cancer Stage IIIB+2 more
Jiangxi Provincial People's Hopital 100
Large-scale testing (Phase 3)Looking for participantsNCT07416474
What this trial is testing

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
RemeGen Co., Ltd. 574
Large-scale testing (Phase 3)Looking for participantsNCT07621718
What this trial is testing

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

Who this might be right for
Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more
Revolution Medicines, Inc. 670
Large-scale testing (Phase 3)Study completedNCT05924880
What this trial is testing

A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract Cancers
AstraZeneca 116
Large-scale testing (Phase 3)Study completedNCT00448279
What this trial is testing

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07164690
What this trial is testing

Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy

Who this might be right for
Esophageal AdenocarcinomaRadiotherapy
Fudan University 32
Not applicableUnknownNCT04525313
What this trial is testing

The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 116
Large-scale testing (Phase 3)Study completedNCT00041080
What this trial is testing

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer+2 more
National Cancer Institute (NCI) 139
Testing effectiveness (Phase 2)Looking for participantsNCT06738160
What this trial is testing

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLCStereotactic Body Radiation Therapy (SBRT)Immunotherapy
Fudan University 27
Testing effectiveness (Phase 2)Ended earlyNCT04099888
What this trial is testing

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Who this might be right for
Cholangiocarcinoma
PCI Biotech AS 41
Large-scale testing (Phase 3)Study completedNCT03374488
What this trial is testing

Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 84
Testing effectiveness (Phase 2)Study completedNCT01111461
What this trial is testing

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Who this might be right for
Endometrial Cancer
Eisai Inc. 133
Next Page